Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

UK NHS needs to rethink long-term care

MPs call for system change as chronic conditions account for 70 per cent of yearly healthcare spend

- PMLiVE

Innovation isn’t solely the province of the scientist

Communiqué Awards confirm comms can be innovative, creative and highly effective

- PMLiVE

New NHS CEO announces senior changes

Simon Stevens strengthens leadership within NHS England

UK flag

UK healthcare professionals urged to say ‘no’ to antibiotics

Royal Colleges issues joint statement to members warning of antimicrobial resistance

Boehringer continues award-winning ChatAFib tweet chat

Its next social media discussion follows the programme's Communiqué win

- PMLiVE

Japan first to approve Roche’s lung cancer drug alectinib

Personalised medicine has same target as Pfizer’s Xalkori and Novartis’ Zykadia

- PMLiVE

GSK wins approval for skin cancer drug Mekinist in EU

Will compete with Roche’s Zelboraf and BMS’ Yervoy in melanoma

- PMLiVE

Cello Health Insight appoints Marie Innes

She joins as a director from Kantar Health

- PMLiVE

Honour for mental health campaigner Marjorie Wallace

SANE founder receives healthcare advocate prize at Communiqué Awards 2014

- PMLiVE

DJM Digital Solutions is Specialist Consultancy of the Year

Agency takes honour at Communiqué Awards 2014

- PMLiVE

The moving parts of orphan drug development

Tackling rare diseases requires high levels of cooperation, regulatory support and a determination to succeed

- PMLiVE

FDA gives early green light to Spectrum’s lymphoma drug

Beleodaq approved to treat rare cancer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links